Showing results (141-150 of 6,758) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|August 30, 2011
Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label studyManuel Battegay, Keikawus Arasteh, Andreas Plettenberg, et al.Clinical Therapeutics|August 25, 2011
Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitusAndrew Lloyd, Beenish Nafees, Anthony H Barnett, et al.Clinical Therapeutics|August 23, 2011
Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trialJung-Hee Ryu, Young-Tae Jeon, Jung-Won Hwang, et al.Clinical Therapeutics|August 12, 2011
Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertensionHae-Young Lee, Bum-Kee Hong, Wook Jin Chung, et al.Clinical Therapeutics|January 1, 1990
Studies of oral rehydration solutions in animal modelsM J FarthingClinical Therapeutics|July 12, 2011
Rifaximin: new therapeutic indication and future directionsAnastasia Rivkin, Suzanna GimClinical Therapeutics|July 5, 2011
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patientsYoshiharu Horie, Shigeto Kanada, Hirotaka Watada, et al.Clinical Therapeutics|September 3, 2011
Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure managementRobert Petrella, Paul MichailidisClinical Therapeutics|June 4, 2011
Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community settingDaniel Kurnik, Janet Vesterman-Landes, Martin Bialik, et al.Clinical Therapeutics|May 24, 2011
Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group studyM Cristina Castelli, Kristen Friedman, James Sherry, et al.Pageof 676